KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Retained Earnings: 2010-2025

Historic Retained Earnings for Nektar Therapeutics (NKTR) over the last 15 years, with Sep 2025 value amounting to -$3.7 billion.

  • Nektar Therapeutics' Retained Earnings fell 3.35% to -$3.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.7 billion, marking a year-over-year decrease of 3.35%. This contributed to the annual value of -$3.6 billion for FY2024, which is 3.42% down from last year.
  • As of Q3 2025, Nektar Therapeutics' Retained Earnings stood at -$3.7 billion, which was down 0.96% from -$3.7 billion recorded in Q2 2025.
  • Nektar Therapeutics' Retained Earnings' 5-year high stood at -$2.4 billion during Q1 2021, with a 5-year trough of -$3.7 billion in Q3 2025.
  • For the 3-year period, Nektar Therapeutics' Retained Earnings averaged around -$3.5 billion, with its median value being -$3.6 billion (2024).
  • Data for Nektar Therapeutics' Retained Earnings shows a maximum YoY decreased of 22.76% (in 2021) over the last 5 years.
  • Over the past 5 years, Nektar Therapeutics' Retained Earnings (Quarterly) stood at -$2.8 billion in 2021, then decreased by 13.00% to -$3.2 billion in 2022, then decreased by 8.62% to -$3.5 billion in 2023, then declined by 3.42% to -$3.6 billion in 2024, then decreased by 3.35% to -$3.7 billion in 2025.
  • Its Retained Earnings was -$3.7 billion in Q3 2025, compared to -$3.7 billion in Q2 2025 and -$3.6 billion in Q1 2025.